case_images: PMC5338054_01
case_images: Central fibrosis and subretinal hemorrhage in the area consistent with the penetration site, which was paracentral to the macula, following pars plana vitrectomy
case_images: OJO-10-44-g001.jpg
case_images: PMC5338054_01_OJO-10-44-g001.jpg
case_images: F1
case_images: A subretinal hemorrhage was seen at the penetration site on fundus examination, and CNV development was assumed [Figure 1].
case_images: Hyperfluorescent appearance consistent with classic choroidal neovascularization and fibrotic retraction is observed with fluorescein angiography
case_images: OJO-10-44-g002.jpg
case_images: PMC5338054_01_OJO-10-44-g002.jpg
case_images: F2
case_images: Optical coherence tomography revealed pigment epithelial detachment, subretinal fluid, and fibrosis in the left eye, consistent with CNV [Figure 2].
case_images: Choroidal neovascularization, subretinal fluid, and fibrosis are observed in the macula with optical coherence tomography
case_images: OJO-10-44-g003.jpg
case_images: PMC5338054_01_OJO-10-44-g003.jpg
case_images: F3
case_images: Fundus fluorescein angiography revealed an occult CNV and fibrosis in the juxtafoveal area [Figure 3].
case_images: Fibrovascular subretinal scar are observed in the macula with optical coherence tomography at the 6th-month follow-up after the injections
case_images: OJO-10-44-g004.jpg
case_images: PMC5338054_01_OJO-10-44-g004.jpg
case_images: F4
case_images: The CNV had regressed at the 6-month follow-up after the injections, but the final visual acuity in the left eye remained at the level of counting fingers at 1 m due to the fibrovascular subretinal scar development [Figure 4].